Bullous pemphigoid (BP) is the most frequent autoimmune subepidermal blistering disease associated with an autoantibody response directed against the BP antigen 180 (BP180, BPAG2 or type XVII collagen) and the BP antigen 230 (BP230 or BPAG1-e). This evidence concerns the gene COL17A1 and bullous pemphigoid.